IGC Pharma
IGC
#10538
Rank
A$44.73 M
Marketcap
A$0.43
Share price
-7.16%
Change (1 day)
-34.16%
Change (1 year)
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -A$9.75 Million

According to IGC Pharma's latest financial reports the company's current earnings are A$1.18 Million. In 2025 the company made an earning of -A$7.46 Million, an increase over its 2024 earnings that were of -A$12.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.75 Million30.6%
2025 -A$7.46 Million-39.35%
2024 -A$12.3 Million-37.72%
2023 -A$19.75 Million1.19%
2022 -A$19.52 Million21.96%
2021 -A$16 Million27.13%
2020 -A$12.59 Million57.16%
2019 -A$8.01 Million85.47%
2018 -A$4.32 Million52.76%
2017 -A$2.83 Million-16.23%
2016 -A$3.38 Million-28.75%
2015 -A$4.74 Million-19.59%
2014 -A$5.89 Million6.79%
2013 -A$5.52 Million-9.47%
2012 -A$6.1 Million-74.03%
2011 -A$23.46 Million119.78%
2010 -A$10.68 Million62.02%
2009 -A$6.59 Million74.39%
2008 -A$3.78 Million-313.12%
2007 A$1.77 M-35.94%
2006 A$2.76 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
A$0.68 B-7,556.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$0.90 B-9,990.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
A$0.39 B-4,382.25%๐Ÿ‡บ๐Ÿ‡ธ USA